Download Image
    
Share
  
Post
Sentinox for COVID-19
1 study with 39 patients
Hospital Icon Control Serious Outcome Risk
Hospital Icon Sentinox
Significantly lower risk for viral clearance.
COVID-19 Sentinox studies. Jan 2026. c19early.org
0 0.5 1 1.5+ All studies 37% Viral clearance 29% RCTs 37% Early 37% Favorssentinox Favorscontrol
May 12
2022
 Panatto et al., Viruses, doi:10.3390/v14051033 Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study
29% improved viral clearance (p=0.01). RCT 57 mild COVID-19 patients showing non-significant viral load reduction with Sentinox (STX), a hypochlorous acid nasal spray. The proportion of COVID negative patients by day 5 was significantly higher in the STX-3 group than controls...